1,123 results on '"Herms, Jochen"'
Search Results
202. 7. Function of Cellular Prion Protein (PrPC) in Copper Homeostasis and Redox Signaling at the Synapse
203. Medullomyoblastoma: a histological, immunohistochemical, ultrastructural and molecular genetic study
204. Imaging Glioma Cell Invasion In Vivo Reveals Mechanisms of Dissemination and Peritumoral Angiogenesis
205. L-type amino acid transporter (LAT) 1 expression in 18F-FET-negative gliomas.
206. Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics.
207. Glitter in the Darkness? Non-fibrillar β-amyloid Plaque Components Significantly Impact the β-amyloid PET Signal in Mouse Models of Alzheimer’s Disease.
208. The cellular prion protein binds copper in vivo
209. Absence of mutations in the AKT1 oncogene in glioblastomas and medulloblastomas
210. Early and longitudinal microglial activation but not amyloid accumulation predict cognitive outcome in PS2APP mice
211. Increasing fibrillar amyloidosis is associated with improved cognition and synaptic preservation caused by microglia modulation
212. Changes in the expression of synapsin I and II messenger RNA during postnatal rat brain development
213. Amyloid precursor protein intracellular domain modulates cellular calcium homeostasis and ATP content
214. Cellular prion protein modulates the intracellular calcium response to hydrogen peroxide
215. Loss of the cellular prion protein affects the Ca2+ homeostasis in hippocampal CA1 neurons
216. Changes of synapsin I messenger RNA expression during rat brain development
217. Superiority of Formalin-Fixed Paraffin-Embedded Brain Tissue for in vitro Assessment of Progressive Supranuclear Palsy Tau Pathology With [ 18 F]PI-2620.
218. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
219. Modulation of L-type voltage-gated calcium channels by recombinant prion protein
220. Cellular prion protein function in copper homeostasis and redox signalling at the synapse
221. Clinical findings in sporadic Creutzfeldt–Jakob disease correlate with thalamic pathology
222. Low Frequency of Chromosomal Imbalances in Anaplastic Ependymomas as Detected by Comparative Genomic Hybridization
223. Clonal Analysis in Glioblastoma with Epithelial Differentiation
224. Altered Intracellular Calcium Homeostasis in Cerebellar Granule Cells of Prion Protein-Deficient Mice
225. TERT-Promoter Mutational Status in Glioblastoma – Is There an Association With Amino Acid Uptake on Dynamic 18F-FET PET?
226. Comparison of 18F-T807 and 18F-THK5117 PET in a Mouse Model of Tau Pathology
227. Additional file 4: of The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
228. Additional file 3: of The Trem2 R47H Alzheimerâ s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
229. Additional file 2: of The Trem2 R47H Alzheimerâ s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
230. Additional file 5: of The Trem2 R47H Alzheimerâ s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
231. Microglial Response to Increasing Amyloidosis Saturates During Aging of an Alzheimer's Disease Mouse Model
232. Additional file 1: of The Trem2 R47H Alzheimer’s risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans
233. Bevacizumab reduces toxicity of reirradiation in recurrent high-grade glioma
234. Early defects in translation elongation factor 1α levels at excitatory synapses in α-synucleinopathy
235. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic 18F-FET PET
236. Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
237. The neuropathology of fatal encephalomyelitis in human Borna virus infection
238. Longitudinal PET Monitoring of Amyloidosis and Microglial Activation in a Second-Generation Amyloid-β Mouse Model
239. P2-376: 18F-PI2620 TAU-PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI-CENTER EVALUATION
240. IC‐P‐161: 18F‐PI2620 TAU‐PET IN PROGRESSIVE SUPRANUCLEAR PALSY: A MULTI‐CENTER EVALUATION
241. Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice
242. In vivoimaging reveals reduced activity of neuronal circuits in a mouse tauopathy model
243. Translational control in brain pathologies: biological significance and therapeutic opportunities
244. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
245. Publisher Correction: ApoE attenuates unresolvable inflammation by complex formation with activated C1q
246. ApoE attenuates unresolvable inflammation by complex formation with activated C1q
247. In vivo Ca 2+ imaging of astrocytic microdomains reveals a critical role of the amyloid precursor protein for mitochondria
248. Loss of TREM2 function increases amyloid seeding but reduces plaque-associated ApoE
249. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study
250. Consequences of Pharmacological BACE Inhibition on Synaptic Structure and Function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.